-
EP2004184
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2004184
| EP2004184 - COMBINATIONS OF THERAPEUTIC AGENTS FOR TREATING CANCER [Right-click to bookmark this link] | Status | The application has been withdrawn Status updated on 11.04.2014 Database last updated on 09.07.2024 | Most recent event Tooltip | 11.04.2014 | Withdrawal of application | published on 14.05.2014 [2014/20] | Applicant(s) | For:BE
BG
CH
CY
CZ
DE
DK
EE
ES
FI
FR
GB
GR
HU
IE
IS
IT
LI
LT
LU
LV
MC
MT
NL
PL
PT
RO
SE
SI
SK
TR
Novartis AG Lichtstrasse 35 4056 Basel / CH | For:AT
Novartis Pharma GmbH Brunner Strasse 59 1230 Wien / AT | [N/P] |
| Former [2009/43] | For:BE
BG
CH
CY
CZ
DE
DK
EE
ES
FI
FR
GB
GR
HU
IE
IS
IT
LI
LT
LU
LV
MC
MT
NL
PL
PT
RO
SE
SI
SK
TR
NOVARTIS AG Lichtstrasse 35 4056 Basel / CH | ||
| For:AT
Novartis Pharma GmbH Brunner Strasse 59 1230 Wien / AT | |||
| Former [2008/52] | For:BE
BG
CH
CY
CZ
DE
DK
EE
ES
FI
FR
GB
GR
HU
IE
IS
IT
LI
LT
LU
LV
MC
MT
NL
PL
PT
RO
SE
SI
SK
TR
NOVARTIS AG Lichtstrasse 35 4056 Basel / CH | ||
| For:AT
Novartis Pharma GmbH Brunner Strasse 59 1230 Vienna / AT | Inventor(s) | 01 /
BURKE, Gregory 61 Heritage Court Randolph, New Jersey 07869 / US | 02 /
LINNARTZ, Ronald, Richard 42 Indian Trail Andover, New Jersey 07821 / US | 03 /
MCSHEEHY, Paul M.J. Maienbuehlweg 5a 79540 Loerrach-Stetten / DE | 04 /
VERSACE, Richard, William 69 Townsend Road Wanaque, New Jersey 07465 / US | 05 /
WARTMANN, Markus Kornfeldstr. 14 CH-4125 Riehen / CH | [2008/52] | Representative(s) | Roth, Peter Richard, et al Novartis Pharma AG Patent Department 4002 Basel / CH | [N/P] |
| Former [2008/52] | Roth, Peter Richard, et al Novartis Pharma AG Patent Department 4002 Basel / CH | Application number, filing date | 07781281.6 | 04.04.2007 | [2008/52] | WO2007US65908 | Priority number, date | US20060789402P | 05.04.2006 Original published format: US 789402 P | [2008/52] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2007121088 | Date: | 25.10.2007 | Language: | EN | [2007/43] | Type: | A2 Application without search report | No.: | EP2004184 | Date: | 24.12.2008 | Language: | EN | The application published by WIPO in one of the EPO official languages on 25.10.2007 takes the place of the publication of the European patent application. | [2008/52] | Search report(s) | International search report - published on: | EP | 06.03.2008 | Classification | IPC: | A61K31/425 | [2008/52] | CPC: |
A61K31/425 (EP,KR,US);
A61K45/06 (EP,US);
A61P35/00 (EP);
A61P43/00 (EP)
| C-Set: |
A61K31/425, A61K2300/00 (EP,US)
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, PL, PT, RO, SE, SI, SK, TR [2008/52] | Title | German: | KOMBINATIONEN VON THERAPEUTISCHEN WIRKSTOFFEN ZUR KREBSBEHANDLUNG | [2008/52] | English: | COMBINATIONS OF THERAPEUTIC AGENTS FOR TREATING CANCER | [2008/52] | French: | COMBINAISONS D'AGENTS THÉRAPEUTIQUES POUR TRAITER UN CANCER | [2008/52] | Entry into regional phase | 05.11.2008 | National basic fee paid | 05.11.2008 | Designation fee(s) paid | 05.11.2008 | Examination fee paid | Examination procedure | 05.11.2008 | Examination requested [2008/52] | 17.12.2008 | Amendment by applicant (claims and/or description) | 08.04.2014 | Application withdrawn by applicant [2014/20] | Fees paid | Renewal fee | 16.04.2009 | Renewal fee patent year 03 | 25.03.2010 | Renewal fee patent year 04 | 12.04.2011 | Renewal fee patent year 05 | 30.03.2012 | Renewal fee patent year 06 | 12.04.2013 | Renewal fee patent year 07 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [XY]WO9943320 (NOVARTIS AG [CH], et al) [X] 1-5,10-14,19-22,26-31 * abstract * * page 4 * * page 9 * * page 17 - page 19 * * page 23 - page 38 * [Y] 6-9,15-18,23-25,32-35; | [A]WO03074521 (UNIV NOTRE DAME [US], et al) [A] * abstract * * page 6 - page 8 *; | [A]WO2004026254 (SQUIBB BRISTOL MYERS CO [US], et al) [A] * abstract * * page 1, line 15 - line 25 *; | [Y] - HANKE J H ET AL, "DISCOVERY OF A NOVEL, POTENT, AND SRC FAMILY-SELECTIVE TYROSINE KINASE INHIBITOR", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY OF BIOLOCHEMICAL BIOLOGISTS, BIRMINGHAM,, US, (19960112), vol. 271, no. 2, ISSN 0021-9258, pages 695 - 701, XP002051826 [Y] 6-9,15-18,23-25,32-35 * abstract * * figure 1 * DOI: http://dx.doi.org/10.1074/jbc.271.2.695 | [A] - BOLLAG D M, "ONCOLOGIC, ENDOCRINE & METABOLIC EPOTHILONES: NOVEL MICROTUBULE-STABILISING AGENTS", EXPERT OPINION ON INVESTIGATIONAL DRUGS, ASHLEY PUBLICATIONS LTD., LONDON, GB, (199707), vol. 6, no. 7, ISSN 1354-3784, pages 867 - 873, XP000991354 [A] 1-35 * abstract * DOI: http://dx.doi.org/10.1517/13543784.6.7.867 | [A] - BOLLAG ET AL, "Epothilones a new class of microtubule-stabilizing agents with a taxol-like mechanism of action", CANCER RESEARCH, AMERICAN ASSOCIATION FOR CANCER RESEARCH, BALTIMORE, MD, US, (19950601), vol. 55, ISSN 0008-5472, pages 2325 - 2333, XP002111282 [A] * the whole document * | [A] - WILSON M B ET AL, "Selective pyrrolo-pyrimidine inhibitors reveal a necessary role for Src family kinases in Bcr-Abl signal transduction and oncogenesis", ONCOGENE 21 NOV 2002 UNITED KINGDOM, (20021121), vol. 21, no. 53, ISSN 0950-9232, pages 8075 - 8088, XP002457687 [A] * abstract * DOI: http://dx.doi.org/10.1038/sj.onc.1206008 |